Literature DB >> 10926707

Bacteriology and antimicrobial choice in hepatolithiasis.

S Sheen-Chen1, W Chen, H Eng, C Sheen, F Chou, Y Cheng, T Lee.   

Abstract

BACKGROUND AND AIMS: Hepatolithiasis is prevalent in southeast Asia and presents a difficult management problem. Acute repeated episodes of cholangitis are frequently manifested in patients with hepatolithiasis. Without proper treatment, such infection can lead to liver abscess, secondary biliary cirrhosis, portal hypertension, and death from sepsis or hepatic failure. In addition to clearance of the stones and relief of bile stasis either by surgery or by interventional radiologic manipulation, effective antimicrobial therapy also plays a crucial role in the treatment of patients with hepatolithiasis. The aim of this study is to clarify the bacteriology in hepatolithiasis and to provide the information for an appropriate antimicrobial choice.
METHODS: From July 1993 to June 1996, 150 patients with hepatolithiasis underwent surgical intervention. Bile specimens were routinely obtained by syringe aspiration from common bile duct. The syringe was immediately capped, and the bile was subsequently cultured for both aerobes and anaerobes.
RESULTS: Bacteria were present in the bile of all patients. The bacteria most frequently found were gram-negative bacteria such as Klebsiella sp, Escherichia coli, and Pseudomonas sp, and the gram-positive Enterococcus sp. Bacteroides sp were the most frequently found anaerobes.
CONCLUSIONS: This study demonstrated the close relationship between acute cholangitis in hepatolithiasis and enteric bacteria and also displayed the detailed antibiotic sensitivity results. Armed with this fruitful information, we believe the antibiotic treatment for acute cholangitis in hepatolithiasis should first aim at enteric bacteria and be adjusted later according to the results of bacteriologic cultures and clinical situation to achieve an effective microbial control.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10926707     DOI: 10.1067/mic.2000.107071

Source DB:  PubMed          Journal:  Am J Infect Control        ISSN: 0196-6553            Impact factor:   2.918


  17 in total

1.  Role of ciprofloxacin in patients with cholestasis after endoscopic retrograde cholangiopancreatography.

Authors:  Thawee Ratanachu-ek; Pitchaya Prajanphanit; Kawin Leelawat; Suchart Chantawibul; Sukij Panpimanmas; Somboon Subwongcharoen; Jerasak Wannaprasert
Journal:  World J Gastroenterol       Date:  2007-01-14       Impact factor: 5.742

2.  Prophylactic antibiotic guidelines in modern interventional radiology practice.

Authors:  Eunice Moon; Matthew D B S Tam; Raghid N Kikano; Karunakaravel Karuppasamy
Journal:  Semin Intervent Radiol       Date:  2010-12       Impact factor: 1.513

Review 3.  The immunobiology of cholangiocytes.

Authors:  Xian-Ming Chen; Steven P O'Hara; Nicholas F LaRusso
Journal:  Immunol Cell Biol       Date:  2008-05-27       Impact factor: 5.126

Review 4.  Advances in cholangiocyte immunobiology.

Authors:  Gaurav Syal; Michel Fausther; Jonathan A Dranoff
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2012-09-06       Impact factor: 4.052

5.  Pathogenesis and Management of Hepatolithiasis: A Report of Two Cases.

Authors:  Biswajit Dey; Gourav Kaushal; Sajini Elizabeth Jacob; Adarsh Barwad; Biju Pottakkat
Journal:  J Clin Diagn Res       Date:  2016-03-01

6.  Bile infection contributes to intrahepatic calculi formation after excision of choledochal cysts.

Authors:  Kenitiro Kaneko; Hisami Ando; Takahiko Seo; Yasuyuki Ono; Keiko Ochiai; Yukio Ogura
Journal:  Pediatr Surg Int       Date:  2005-01       Impact factor: 1.827

7.  The frequency of live bacteria in gallstones.

Authors:  P Hazrah; K T H Oahn; M Tewari; A K Pandey; K Kumar; T M Mohapatra; H S Shukla
Journal:  HPB (Oxford)       Date:  2004       Impact factor: 3.647

Review 8.  Significance of controlling chronic proliferative cholangitis in the treatment of hepatolithiasis.

Authors:  Fu Yu Li; Nan Sheng Cheng; Hui Mao; Li Sheng Jiang; Jing Qiu Cheng; Quan Sheng Li; Sanjay Munireddy
Journal:  World J Surg       Date:  2009-10       Impact factor: 3.352

9.  Lipopolysaccharide induces overexpression of MUC2 and MUC5AC in cultured biliary epithelial cells: possible key phenomenon of hepatolithiasis.

Authors:  Yoh Zen; Kenichi Harada; Motoko Sasaki; Koichi Tsuneyama; Kazuyoshi Katayanagi; Yui Yamamoto; Yasuni Nakanuma
Journal:  Am J Pathol       Date:  2002-10       Impact factor: 4.307

Review 10.  Biliary innate immunity: function and modulation.

Authors:  Kenichi Harada; Yasuni Nakanuma
Journal:  Mediators Inflamm       Date:  2010-07-27       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.